A total of 455 patients was screened for participation in this study. Of these, 76 patients failed the screening process. Three patients had a placebo run-in visit but did not receive any placebo ...
Conclusion: These results show that there is little or no potential for a clinically relevant pharmacokinetic interaction between olmesartan medoxomil 20mg and hydrochlorothiazide 25mg ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback